Pharma
Dapefy SM (Dapagliflozin, Sitagliptin and Metformin ER Tablets)
Triple antidiabetic combo; Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin ER 1000 mg (28 tablets) for Type 2 Diabetes.
Dapefy SM (Dapagliflozin, Sitagliptin and Metformin ER Tablets)
Dapefy SM is a triple-action antidiabetic medication. It combines Dapagliflozin (10 mg), Sitagliptin (100 mg), and Extended-Release Metformin HCl (1000 mg). This pack contains 28 tablets (4x7's Tablets). By combining an SGLT2 inhibitor, a DPP-4 inhibitor, and a biguanide, it addresses glycemic control through multiple pathways: increasing urinary glucose excretion, enhancing insulin secretion, and reducing hepatic glucose production. It is used for the management of type 2 diabetes mellitus.
You May Also Like
Combination DPP-4 inhibitor and Biguanide; 50 mg/500 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/1000 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50mg/500mg Vildagliptin/Metformin tablets for Type 2 Diabetes control.
Antidiabetic combination; Empagliflozin 12.5 mg and Metformin 1000 mg (28 tablets) for Type 2 Diabetes management.